| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Academic collaborative models fostering the translation of physiological in vitro systems from basic research into drug discovery
|
Silvestri, Alessandra
|
|
|
26 |
6 |
p. 1369-1381
|
artikel
|
| 2 |
Advanced nanodelivery platforms for topical ophthalmic drug delivery
|
Gholizadeh, Shima
|
|
|
26 |
6 |
p. 1437-1449
|
artikel
|
| 3 |
Allosteric mutant-selective fourth-generation EGFR inhibitors as an efficient combination therapeutic in the treatment of non-small cell lung carcinoma
|
Tripathi, Surya Kant
|
|
|
26 |
6 |
p. 1466-1472
|
artikel
|
| 4 |
A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune system
|
Sofias, Alexandros Marios
|
|
|
26 |
6 |
p. 1482-1489
|
artikel
|
| 5 |
Autophagy-regulating miRNAs: potential targets for obesity and related metabolic disorders
|
Zhang, Tian
|
|
|
26 |
6 |
p. 1532-1538
|
artikel
|
| 6 |
Benchmarking the mechanisms of frequent hitters: limitation of PAINS alerts
|
Yang, Zi-Yi
|
|
|
26 |
6 |
p. 1353-1358
|
artikel
|
| 7 |
Biofilm control by ionic liquids
|
Simões, Manuel
|
|
|
26 |
6 |
p. 1340-1346
|
artikel
|
| 8 |
Cancer vaccines: An unkept promise?
|
Kamath, Vignesh
|
|
|
26 |
6 |
p. 1347-1352
|
artikel
|
| 9 |
Computational avenues in oral protein and peptide therapeutics
|
Pandya, Anjali K.
|
|
|
26 |
6 |
p. 1510-1520
|
artikel
|
| 10 |
Contents page 1
|
|
|
|
26 |
6 |
p. i
|
artikel
|
| 11 |
Contents page 2
|
|
|
|
26 |
6 |
p. ii
|
artikel
|
| 12 |
Converting peptides into drugs targeting intracellular protein–protein interactions
|
Philippe, Grégoire J.B.
|
|
|
26 |
6 |
p. 1521-1531
|
artikel
|
| 13 |
Driving success in personalized medicine through AI-enabled computational modeling
|
Chakravarty, Kaushik
|
|
|
26 |
6 |
p. 1459-1465
|
artikel
|
| 14 |
From recipe to research: introducing undergraduate students to the nature of science using a hybrid practical course centred on drug discovery for neglected diseases
|
Wijtmans, Maikel
|
|
|
26 |
6 |
p. 1359-1368
|
artikel
|
| 15 |
Graph neural networks for automated de novo drug design
|
Xiong, Jiacheng
|
|
|
26 |
6 |
p. 1382-1393
|
artikel
|
| 16 |
Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
|
Collier, Mary EW
|
|
|
26 |
6 |
p. 1473-1481
|
artikel
|
| 17 |
New views on endothelial dysfunction in gestational hypertension and potential therapy targets
|
Feng, Xueqin
|
|
|
26 |
6 |
p. 1420-1436
|
artikel
|
| 18 |
PepTherDia: database and structural composition analysis of approved peptide therapeutics and diagnostics
|
D’Aloisio, Vera
|
|
|
26 |
6 |
p. 1409-1419
|
artikel
|
| 19 |
Point-of-care diagnostics approaches for detection of lung cancer-associated circulating miRNAs
|
Shandilya, Ruchita
|
|
|
26 |
6 |
p. 1501-1509
|
artikel
|
| 20 |
Potential and promising anticancer drugs from adenosine and its analogs
|
Man, Shuli
|
|
|
26 |
6 |
p. 1490-1500
|
artikel
|
| 21 |
Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic
|
Oo, Charles
|
|
|
26 |
6 |
p. 1337-1339
|
artikel
|
| 22 |
Role of STAT3 signaling transduction pathways in cancer stem cell-associated chemoresistance
|
Shih, Po-Chang
|
|
|
26 |
6 |
p. 1450-1458
|
artikel
|
| 23 |
Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases
|
Vong, Chi Teng
|
|
|
26 |
6 |
p. 1394-1408
|
artikel
|
| 24 |
Toward improving androgen receptor-targeted therapies in male-dominant hepatocellular carcinoma
|
Zhang, Hong
|
|
|
26 |
6 |
p. 1539-1546
|
artikel
|
| 25 |
Unleashing bioprinting technology through patent intelligence
|
Parikh, Meghana Tushar
|
|
|
26 |
6 |
p. 1547-1555
|
artikel
|
Tijdschrift beschrijving